Protocol liver biopsies in stable long-term pediatric liver transplant recipients: risk or benefit?
- PMID: 33405423
- DOI: 10.1097/MEG.0000000000002006
Protocol liver biopsies in stable long-term pediatric liver transplant recipients: risk or benefit?
Abstract
Background: Follow-up after pediatric liver transplantation (LTX) is challenging and needs to be refined to extend graft survival as well as general functional health and patients´ quality of life. Strategies towards individual immunosuppressive therapy seem to play a key role. Our aim was to evaluate protocol liver biopsies (PLB) as a tool in personalized follow up after pediatric LTX.
Patients and methods: Our retrospective analysis evaluates 92 PLB in clinically asymptomatic pediatric patients after LTX between 2009 and 2019. Histological findings were characterized using the Desmet scoring system. In addition to PLB, other follow-up tools like laboratory parameters, ultrasound imaging and transient elastography were evaluated. Risk factors for development of fibrosis or inflammation were analyzed.
Results: PLB revealed a high prevalence of graft fibrosis (67.4%) and graft inflammation (47.8%). Graft inflammation was significantly (P = 0.0353*) more frequent within the first 5 years after transplantation compared to later time points. Besides conventional ultrasound, the measurement of liver stiffness using transient elastography correlate with stage of fibrosis (r = 0.567, P = <0.0001***). Presence of donor-specific anti-human leukocyte antigen antibodies in blood correlates with grade of inflammation in PLB (r = 0.6040, P = 0.0018 **). None of the patients who underwent PLB suffered from intervention-related complications. Histopathological results had an impact on clinical decision making in one-third of all patients after PLB.
Conclusion: PLB are a safe and useful tool to detect silent immune-mediated allograft injuries in the context of normal liver parameters.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
References
-
- Starzl TE, Koep LJ, Schröter GP, Halgrimson CG, Porter KA, Weil R 3rd. Liver replacement for pediatric patients. Pediatrics 1979; 63:825–829.
-
- Martinelli J, Habes D, Majed L, Guettier C, Gonzalès E, Linglart A, et al. Long-term outcome of liver transplantation in childhood: a study of 20-year survivors. Am J Transplant 2018; 18:1680–1689.
-
- Wallot MA, Mathot M, Janssen M, Hölter T, Paul K, Buts JP, et al. Long-term survival and late graft loss in pediatric liver transplant recipients–a 15-year single-center experience. Liver Transpl 2002; 8:615–622.
-
- Martin SR, Atkison P, Anand R, Lindblad AS; SPLIT Research Group. Studies of Pediatric Liver Transplantation 2002: patient and graft survival and rejection in pediatric recipients of a first liver transplant in the United States and Canada. Pediatr Transplant 2004; 8:273–283.
-
- Ng VL, Alonso EM, Bucuvalas JC, Cohen G, Limbers CA, Varni JW, et al.; Studies of Pediatric Liver Transplantation (SPLIT) Research Group. Health status of children alive 10 years after pediatric liver transplantation performed in the US and Canada: report of the studies of pediatric liver transplantation experience. J Pediatr 2012; 160:820–6.e3.
MeSH terms
LinkOut - more resources
Medical